Letter to the Editor: Suggestions for Rational Management of Nonalcoholic Fatty Liver Disease

Lei Luo^{1

2}, Huaibin Zou², Sujun Zheng², Zhongping Duan², Yu Chen²

Affiliations

¹ Department of Infectious Diseases, Nanchang University Second Affiliated Hospital, Nanchang, China.
² Difficult & Complicated Liver Diseases and Artificial Liver Center, Beijing Youan Hospital, Capital Medical University, Beijing, China.

Comment

Lei Luo et al. Hepatology. 2019 Oct.

. 2019 Oct;70(4):1492-1493.

doi: 10.1002/hep.30797.

Lei Luo^{1

2}, Huaibin Zou², Sujun Zheng², Zhongping Duan², Yu Chen²

¹ Department of Infectious Diseases, Nanchang University Second Affiliated Hospital, Nanchang, China.
² Difficult & Complicated Liver Diseases and Artificial Liver Center, Beijing Youan Hospital, Capital Medical University, Beijing, China.

No abstract available

Comment in

Reply.
Allen AM, Talwalkar JA, McCoy RG. Allen AM, et al. Hepatology. 2019 Oct;70(4):1493-1494. doi: 10.1002/hep.30796. Hepatology. 2019. PMID: 31152591 No abstract available.

Healthcare Cost and Utilization in Nonalcoholic Fatty Liver Disease: Real-World Data From a Large U.S. Claims Database.
Allen AM, Van Houten HK, Sangaralingham LR, Talwalkar JA, McCoy RG. Allen AM, et al. Hepatology. 2018 Dec;68(6):2230-2238. doi: 10.1002/hep.30094. Epub 2018 Sep 20. Hepatology. 2018. PMID: 29774589 Free PMC article.